Evidence map›Paper›PMID 33981684›Full record

ArticleGastrointestinal tumors2021

Screening Status as a Determinant of Choice of Colorectal Cancer Screening Method: A Population-Based Informed Survey.

José Luis Sandoval, Allan Relecom, Cyril Ducros, Jean-Luc Bulliard, Beatrice Arzel, Idris Guessous

Open access · goldAbstract read
In one paragraph

Article in Gastrointestinal tumors, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

José Luis SandovalUnit of Population Epidemiology, Division of Primary Care Medicine, Department of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.
Allan RelecomDepartment of Oncology, Geneva University Hospitals, Geneva, Switzerland.
Cyril DucrosVaud Cancer Screening Foundation, Lausanne, Switzerland.
Jean-Luc BulliardInstitute of Social and Preventive Medicine, University Hospital of Lausanne, Lausanne, Switzerland.
Beatrice ArzelGeneva Cancer Screening Foundation, Geneva, Switzerland.
Idris GuessousUnit of Population Epidemiology, Division of Primary Care Medicine, Department of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.
University Hospital of Geneva · CHSwiss Cancer Center Léman · CHUniversity Hospital of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesFecal blood testing is a noninvasive alternative to colonoscopy for colorectal cancer (CRC) screening and is preferred by a substantial proportion of individuals. However, participant-related determinants of the choice of screening method, particularly up-to-date screening status, remain less studied. We aimed to determine if up-to-date screening status was related to choosing a fecal blood test over colonoscopy.

settingParticipants in the population-based cross-sectional survey study Bus Santé in Geneva, Switzerland - aged 50-69 years.

designCross-sectional survey study using mailed questionnaires inquiring about CRC screening method of choice after providing information on advantages and disadvantages of both screening methods. We used multivariable logistic regression models to determine the association between up-to-date CRC screening status and choosing fecal blood testing. KEY

resultsWe included 1,227 participants. Thirty-eight percent of participants did not have up-to-date CRC screening. Overall, colonoscopy (54.9%) was preferred to fecal blood testing (45.1%) (

conclusionsNot having up-to-date screening was independently associated with fecal blood testing as the preferred method for CRC screening. Proposing this method to this subpopulation, in a context of shared decision, could potentially increase screening uptake in settings where it is already high.

Indexed as

Colon cancerColonoscopyFecal blood testingPatient choiceScreening

Identifiers

PMID33981684
PMCPMC8077459
OpenAlexW3145147893

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.